Docherty J R, Brady G
Department of Physiology, Royal College of Surgeons in Ireland, Dublin.
Eur J Pharmacol. 1995 Dec 20;287(3):287-93. doi: 10.1016/0014-2999(95)00495-5.
In studies of isometric contractions in prostatic portions of rat vas deferens evoked by single pulse electrical stimulation, the K+ channel blockers 4-aminopyridine, tetraethylammonium and charybdotoxin, but not apamin, significantly reduced the prejunctional inhibitory potency and the maximum inhibitory effect of the alpha 2-adrenoceptor agonist xylazine. The protein kinase C activator phorbol dibutyrate had similar effects to 4-aminopyridine against xylazine. However, 4-aminopyridine, tetraethylammonium, charybdotoxin and phorbol dibutyrate, but not apamin, significantly increased the magnitude of the isometric contraction to a single stimulus. 4-Aminopyridine and phorbol dibutyrate significantly reduced, while tetraethylammonium did not affect, isometric contractions to noradrenaline, and 4-aminopyridine failed to affect contractions to alpha,beta-methylene-ATP, so that the effects of these agents on the isometric contraction to a single stimulus were presumably by a prejunctional action. The Ca2+ entry facilitator Bay K 8644 (1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-pyrid ine carboxylic acid methylester) increased stimulation-evoked contractions by a postjunctional action and reduced the inhibitory effects of xylazine. When the isometric contraction following 4-aminopyridine was reduced by decreasing the stimulation voltage or by reducing the Ca2+ concentration from 2.5 to 0.9 mM, 4-aminopyridine significantly reduced the potency of xylazine. However, tetraethylammonium and Bay K 8644 failed to affect the inhibitory potency of xylazine in low Ca2+. It is concluded that the K+ channel blocker 4-aminopyridine reduces the prejunctional inhibitory potency of xylazine, and this action is independent of increased neurotransmitter release. These results suggest that prejunctional alpha 2-adrenoceptor-mediated inhibition in rat vas deferens involves K+ channels sensitive to block by 4-aminopyridine.
在对大鼠输精管前列腺部单脉冲电刺激诱发的等长收缩的研究中,钾离子通道阻滞剂4-氨基吡啶、四乙铵和大蝎毒素(但蜂毒明肽无此作用)显著降低了α₂肾上腺素能受体激动剂赛拉嗪的突触前抑制效能和最大抑制作用。蛋白激酶C激活剂佛波酯二丁酸酯对赛拉嗪的作用与4-氨基吡啶相似。然而,4-氨基吡啶、四乙铵、大蝎毒素和佛波酯二丁酸酯(但蜂毒明肽无此作用)显著增加了对单个刺激的等长收缩幅度。4-氨基吡啶和佛波酯二丁酸酯显著降低了对去甲肾上腺素的等长收缩,而四乙铵未影响对去甲肾上腺素的等长收缩,且4-氨基吡啶未影响对α,β-亚甲基-ATP的收缩,因此这些药物对单个刺激的等长收缩的作用可能是通过突触前作用实现的。钙离子内流促进剂Bay K 8644(1,4-二氢-2,6-二甲基-5-硝基-4-[2-(三氟甲基)-苯基]-3-吡啶羧酸甲酯)通过突触后作用增加了刺激诱发的收缩,并降低了赛拉嗪的抑制作用。当通过降低刺激电压或将钙离子浓度从2.5 mM降至0.9 mM来降低4-氨基吡啶后的等长收缩时,4-氨基吡啶显著降低了赛拉嗪的效能。然而,在低钙条件下,四乙铵和Bay K 8644未能影响赛拉嗪的抑制效能。得出结论:钾离子通道阻滞剂4-氨基吡啶降低了赛拉嗪的突触前抑制效能,且该作用与神经递质释放增加无关。这些结果表明,大鼠输精管中突触前α₂肾上腺素能受体介导的抑制涉及对4-氨基吡啶敏感的钾离子通道。